doctor veronica johnson has seen patients like caitlin in her office. >> insurance sometimes does notognize obesity and overweight as a chronic disease, so it's less likely for them to get coverage for these medications. it's really tough because we see patients who do really well on these very effective drugs, and then they unfortunately, we can't continue coverage varies by insurance company and by drug like ozempic, which is only fda approved for diabetes, not weight loss. >> while another drug with the same ingredient, wegovy, is fda approved for weight loss but remains in short supply. the lack of coverage is frustrating for patients and for many doctors. >> i think insurance always lags behind science, and the more and more data that we have available that these medications not only promote weight loss, but they also improve other metal diseases or cardiovascular diseases. >> but some states and lawmakers are taking the issue into their own hands. earlier this year, bloomberg law reported that nine states have added wegovy to their medicaid preferred drug lists, making it easier